Fig. 1: miR-29c-3p is downregulated in human hepatocellular carcinoma (HCC) samples. | Cell Death & Disease

Fig. 1: miR-29c-3p is downregulated in human hepatocellular carcinoma (HCC) samples.

From: miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma

Fig. 1

a Relative expression of miR-29c-3p in 150 pairs of HCC tissues and paired normal adjacent tissues. b Relative expression of miR-29c-3p expression in aggressive and nonaggressive HCC tissues. c miR-29c-3p expression in HCC tissues and paired normal adjacent tissues. d Relative miR-29c-3p expression in 4 HCC cell lines, and the normal human hepatocyte cell line LO2 served as the control. e Kaplan–Meier analysis of overall survival between high (n = 55) and low (n = 95) miR-29c-3p expression in HCC patients; **p < 0.01, ***p < 0.001

Back to article page